Brief: Unicycive Announces Full Year 2021 Financial Results
March 31 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS INC - AS OF DECEMBER 31, 2021, CASH
AND
CASH EQUIVALENTS TOTALED $16.6 MILLION
* UNICYCIVE THERAPEUTICS INC - PLANS TO INITIATE PHASE 1
STUDY FOR
UNI-494 IN SECOND HALF OF 2022
Source text for Eikon: ID:nGNX5lHPXQ
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss